Association between experimental pain biomarkers and serologic markers in patients with different degrees of painful knee osteoarthritis

Arthritis and Rheumatology

Volumn 66, Issue 12, 2014, Pages 3317-3326

  Arendt Nielsen, Lars ^a   Eskehave, Thomas N ^a   Egsgaard, Line L ^a   Petersen, Kristian K ^a   Graven Nielsen, Thomas ^a   Hoeck, Hans C ^b   Simonsen, Ole ^c   Siebuhr, Anne S ^d   Karsdal, Morten ^d   Bay Jensen, Anne C ^d  

^a AALBORG UNIVERSITY   (Denmark)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^c Vendsyssel Hospital   (Denmark)

^d NORDIC BIOSCIENCE A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; MATRIX METALLOPROTEINASE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BONE; CARTILAGE; CONTROLLED STUDY; EXPERIMENTAL PAIN; FEMALE; HEMATOLOGY ANALYZER; HUMAN; KELLGREN/LAWRENCE SCALE; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PAIN INTENSITY; PRESSURE PAIN THRESHOLD; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL; SENSITIZATION; TEMPORAL SUMMATION; VERY ELDERLY; ARTHRALGIA; COMPLICATION; METABOLISM; MIDDLE AGED; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTSYNAPTIC POTENTIAL SUMMATION; SEVERITY OF ILLNESS INDEX;

AGED; ARTHRALGIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COLLAGEN TYPE I; COLLAGEN TYPE II; COLLAGEN TYPE III; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN THRESHOLD; POSTSYNAPTIC POTENTIAL SUMMATION; SEVERITY OF ILLNESS INDEX;

EID: 84912017984     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38856     Document Type: Article

References (52)

1. Dieppe PA, Lohmander LS,. Pathogenesis and management of pain in osteoarthritis. Lancet 2005; 365: 965-73.
2. Felson DT,. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol 2005; 17: 624-8.
3. Schiphof D, Kerkhof HJ, Damen J, de Klerk BM, Hofman A, Koes BW, et al. Factors for pain in patients with different grades of knee osteoarthritis. Arthritis Care Res (Hoboken) 2013; 65: 695-702.
4. Kavchak AJ, Fernandez-de-Las-Penas C, Rubin LH, Arendt-Nielsen L, Chmell SJ, Durr RK, et al. Association between altered somatosensation, pain, and knee stability in patients with severe knee osteoarthrosis. Clin J Pain 2012; 28: 589-94.
5. Suokas AK, Walsh DA, McWilliams DF, Condon L, Moreton B, Wylde V, et al. Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage 2012; 20: 1075-85.
6. Wylde V, Palmer S, Learmonth ID, Dieppe P,. Somatosensory abnormalities in knee OA. Rheumatology (Oxford) 2012; 51: 535-43.
7. Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, et al. Sensitization in patients with painful knee osteoarthritis. Pain 2010; 149: 573-81.
8. Arendt-Nielsen L, Hoeck HC,. Peripheral and central sensitisation in osteoarthritis: implications for treatment. Eur Musculoskelet Rev 2011; 6: 158-61.
9. Graven-Nielsen T, Wodehouse T, Langford RM, Arendt-Nielsen L, Kidd BL,. Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement. Arthritis Rheum 2012; 64: 2907-16.
10. Finan PH, Buenaver LF, Bounds SC, Hussain S, Park RJ, Haque UJ, et al. Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization. Arthritis Rheum 2013; 65: 363-72.
11. Kumm J, Tamm A, Lintrop M, Tamm A,. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects. Rheumatol Int 2013; 33: 903-11.
12. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E,. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001; 60: 619-26.
13. Bay-Jensen AC, Wichuk S, Byrjalsen I, Leeming DJ, Morency N, Christiansen C, et al. Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis. PLoS One 2013; 8: e54504.
14. Appleton CT, Pitelka V, Henry J, Beier F,. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum 2007; 56: 1854-68.
15. Siebuhr AS, Bay-Jensen AC, Leeming DJ, Platt A, Byrjalsen I, Christiansen C, et al. Serological identification of fast progressors of structural damage with rheumatoid arthritis. Arthritis Res Ther 2013; 15: R86.
16. Bay-Jensen AC, Liu Q, Byrjalsen I, Li Y, Wang J, Pedersen C, et al. Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM: increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem 2011; 44: 423-9.
17. Siebuhr AS, Wang J, Karsdal M, Bay-Jensen AC, Jin Y, Zheng Q,. Matrix metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis. J Transl Med 2012; 10: 195.
18. Siebuhr AS, Petersen KK, Arendt-Nielsen L, Egsgaard LL, Eskehave T, Christiansen C, et al. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover. Osteoarthritis Cartilage 2014; 22: 44-50.
19. Kushner I,. C-reactive protein and the acute-phase response. Hosp Pract (Off Ed) 1990; 25: 13, 16, 21-8.
20. Skjot-Arkil H, Schett G, Zhang C, Larsen DV, Wang Y, Zheng Q, et al. Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis. Clin Exp Rheumatol 2012; 30: 371-9.
21. Jin X, Beguerie JR, Zhang W, Blizzard L, Otahal P, Jones G, et al. Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2013. E-pub ahead of print.
22. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
23. Kellgren JH, Lawrence JS,. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502.
24. Nie H, Arendt-Nielsen L, Andersen H, Graven-Nielsen T,. Temporal summation of pain evoked by mechanical stimulation in deep and superficial tissue. J Pain 2005; 6: 348-55.
25. Veidal SS, Vassiliadis E, Barascuk N, Zhang C, Segovia-Silvestre T, Klickstein L, et al. Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serologic biochemical marker for liver fibrogenesis. Liver Int 2010; 30: 1293-304.
26. Leeming D, He Y, Veidal S, Nguyen Q, Larsen D, Koizumi M, et al. A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers 2011; 16: 616-28.
27. Barascuk N, Vassiliadis E, Larsen L, Wang J, Zheng Q, Xing R, et al. Development and validation of an enzyme-linked immunosorbent assay for the quantification of a specific MMP-9 mediated degradation fragment of type III collagen: a novel biomarker of atherosclerotic plaque remodeling. Clin Biochem 2011; 44: 900-6.
28. Imamura M, Imamura ST, Kaziyama HH, Targino RA, Hsing WT, de Souza LP, et al. Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis. Arthritis Rheum 2008; 59: 1424-31.
29. Cibere J, Zhang H, Garnero P, Poole AR, Lobanok T, Saxne T, et al. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum 2009; 60: 1372-80.
30. Qvist P, Christiansen C, Karsdal MA, Madsen SH, Sondergaard BC, Bay-Jensen AC,. Application of biochemical markers in development of drugs for treatment of osteoarthritis. Biomarkers 2010; 15: 1-19.
31. Garnero P, Mazieres B, Gueguen A, Abbal M, Berdah L, Lequesne M, et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 2005; 32: 697-703.
32. Dam EB, Byrjalsen I, Arendt-Nielsen L, Christiansen C, Karsdal MA,. Relationships between knee pain and osteoarthritis biomarkers based on systemic fluids and magnetic resonance imaging. J Musculoskel Pain 2011; 19: 144-53.
33. Tanishi N, Yamagiwa H, Hayami T, Mera H, Koga Y, Omori G, et al. Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis: the Matsudai knee osteoarthritis survey. J Orthop Sci 2014; 19: 429-36.
34. Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, et al. Serum CrossLaps One Step ELISA: first application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 1998; 44: 2281-9.
35. Henrotin Y, Addison S, Kraus V, Deberg M,. Type II collagen markers in osteoarthritis: what do they indicate? Curr Opin Rheumatol 2007; 19: 444-50.
36. Goldring MB, Otero M,. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011; 23: 471-8.
37. Zhang Y, Nevitt M, Niu J, Lewis C, Torner J, Guermazi A, et al. Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum 2011; 63: 691-9.
38. Pearle AD, Scanzello CR, George S, Mandl LA, DiCarlo EF, Peterson M, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007; 15: 516-23.
39. Schaible HG,. Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep 2012; 14: 549-56.
40. Gwilym SE, Keltner JR, Warnaby CE, Carr AJ, Chizh B, Chessell I, et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum 2009; 61: 1226-34.
41. Rhodes B, Furnrohr BG, Vyse TJ,. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol 2011; 7: 282-9.
42. Bejon P, Byren I, Atkins BL, Scarborough M, Woodhouse A, Lardy-Smith P, et al. Serial measurement of the C-reactive protein is a poor predictor of treatment outcome in prosthetic joint infection. J Antimicrob Chemother 2011; 66: 1590-3.
43. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW,. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833-40.
44. Sturmer T, Brenner H, Koenig W, Gunther KP,. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 2004; 63: 200-5.
45. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997; 40: 723-7.
46. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W,. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763-7.
47. Abou-Raya A, Abou-Raya S, Khadrawi T, Helmii M,. Effect of low-dose oral prednisolone on symptoms and systemic inflammation in older adults with moderate to severe knee osteoarthritis: a randomized placebo-controlled trial. J Rheumatol 2014; 41: 53-9.
48. Stannus OP, Jones G, Blizzard L, Cicuttini FM, Ding C,. Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann Rheum Dis 2013; 72: 535-40.
49. Berenbaum F,. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013; 21: 16-21.
50. Karsdal MA, Henriksen K, Leeming DJ, Woodworth T, Vassiliadis E, Bay-Jensen AC,. Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers: are they the cause or the consequence of the disease? Clin Biochem 2010; 43: 793-804.
51. Felson DT,. The current and future status of biomarkers in osteoarthritis. J Rheumatol 2014; 41: 834-6.
52. Hunter DJ, Nevitt M, Losina E, Kraus V,. Biomarkers for osteoarthritis: current position and steps towards further validation. Best Pract Res Clin Rheumatol 2014; 28: 61-71.